The Cancer Letter: Joint byline, ‘Is gastrectomy indicated?’
A study recently published in JAMA sheds light on cancer risks associated with carrying germline CDH1 mutations, challenging previous, potentially inflated, lifetime cancer risk estimates. InformedDNA, FORCE: Facing Our Risk of Cancer Empowered, and No Stomach For Cancer, collaborate as patient advocates, educators, and experts to support individuals and families impacted by gastric cancer to help them navigate this complex genetic landscape. Subscribers to The Cancer Letter can login to read the full article.
Life Sciences Review: InformedDNA Featured Cover Story, Genetic Testing Edition
Actionable Genomic Insights for Successful Clinical Trials: A powerful genomic force is behind the growing success of clinical trials for drug development of rare diseases. InformedDNA CEO, Dr. Surya Singh shares their winning strategy, powered by their remote genetic experts and deep insights, that boosts accurate patient enrollment, improves retention rates, and empowers informed decision-making for life science clients.
The Cancer Letter: Paired tumor-germline testing can enhance patient care—with guidance from genetics specialists
In a guest byline published in The Cancer Letter, InformedDNA’s chief medical officer and co-founder, Dr. Rebecca Sutphen describes the importance of paired tumor-germline testing in cancer patients and the critical role of genetics specialists in enhancing that care. Subscribers to The Cancer Letter can login to read the full article.
Foundation Fighting Blindness Partners with Prevention Genetics and InformedDNA to Advance My Retina Tracker® Genetic Testing Program
Empowering Healthcare Providers and Patients with Genetic Testing and Genetic Counseling Solutions COLUMBIA, Md., May 15, 2024 /PRNewswire/ — The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announces today its partnership with PreventionGenetics, a part of Exact Sciences, as its new genetic laboratory partner for […]
Industry Veteran Suggests Broader Genomics Use for Proactive Approach to Health Care
Reprinted with AIS Health permission from the January 2024 issue of Radar on Specialty Pharmacy Tremendous strides have been made in personalized medicine over the past several years — not only in drugs but in the various biomarkers used to identify the right drug for the right patient at the right time. While many people […]
Hereditary Neuropathy Foundation Partners with InformedDNA® on CMT Genie Project
NEW YORK, NEW YORK , UNITED STATES, January 10, 2024 /EINPresswire.com/ — In partnership with InformedDNA® , the Hereditary Neuropathy Foundation (HNF) has added more value to their Charcot-Marie-Tooth (CMT) Genie Project — a patient-initiated at-home CMT genetic testing program, providing faster and more equitable access to critical genetic care for the CMT community and […]
HealthHelp and InformedDNA Announce Strategic Partnership
HealthHelp, a leading specialty benefits management and care management company, and InformedDNA, the nation’s leading applied genomics solutions company, announce a new strategic partnership. This alliance extends the value of HealthHelp’s specialty benefits program portfolio with the addition of Genetic Testing Utilization Management (GTUM) through the integration of InformedDNA’s proven genomics expertise and content. The […]
Healthcare News: InformedDNA Acquires gWell Health; Appoints gWell Founder Surya Singh, MD as CEO
Milestone is evidence of the company’s continued evolution to accelerate and increase accessibility to precision medicine St. Petersburg, FL – August 1, 2023 – InformedDNA®, the nation’s leading applied genomics solutions company, announced today its acquisition of gWell Health, a digital health, genomics, and wellness company. InformedDNA’s deep genomic expertise partnered with gWell’s robust technology […]
